Scienture Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Commack, NY
SCNX chart
What traders are saying about $SCNX
Latest postsScienture Holdings, Inc. news
- Form DEF 14C Scienture Holdings Inc For: 9 November By Investing.com
Investing.com India ·
- Scienture Holdings, Inc. (SCNX) Seasonal returns chart
Yahoo Finance UK ·
- Scynexis: Q3 Earnings Snapshot
Yahoo Finance ·
- SCNX Q3'26 Earnings: revenue estimate is 1.22M USD
TradingView ·
- SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Yahoo Finance ·
- SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Yahoo Finance ·
- EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
Yahoo Finance ·
- SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
Yahoo Finance ·
- EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
Yahoo Finance ·
- Scienture Holdings, Inc. Announces Reverse Stock Split
Yahoo Finance ·
- SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Yahoo Finance ·
- SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
Yahoo Finance ·
Scienture Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $431,609 | $136,643 | $1.4M | $10.3M |
| Net income | -$41.5M | $13.6M | -$17.8M | -$3.5M |
| Diluted EPS | $-2.70 | $2.48 | $-23.35 | $-6.13 |
| Total assets (year end) | $84.2M | $104.9M | $12.5M | $3.7M |
| Cash and equivalents (year end) | $6.7M | $308,096 | $361 | $1.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Scienture Holdings, Inc.
- Ticker
- SCNX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Commack, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC.
Frequently asked questions
What exchange is Scienture Holdings, Inc. listed on?
Scienture Holdings, Inc. trades on the Nasdaq under the ticker symbol SCNX.
What industry is Scienture Holdings, Inc. in?
Scienture Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Scienture Holdings, Inc. headquartered?
Scienture Holdings, Inc.'s business address on file with the SEC is in Commack, NY.
When does Scienture Holdings, Inc.'s fiscal year end?
Scienture Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Scienture Holdings, Inc. report?
Scienture Holdings, Inc. reported $431,609 in revenue for calendar year 2025, according to its SEC filings.